Organigram Holdings Inc (OGI) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Organigram Reports Second Quarter Fiscal 2024 Results

21% growth in recreational net revenue year-over-year First Jupiter private placement tranche closed adding $41.5 million of cash bringing...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading...

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the highest executive gender diversity...

Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales

Success of the brand owed to ongoing pipeline of innovative products designed to delight consumers. Organigram Holdings Inc. (NASDAQ: OGI) (TSX:...

Organigram Successfully Closes Previously Announced Underwritten Public Offering

Including over-allotment Company raises C$28.8 million in gross proceeds improving already strong balance sheet Organigram Holdings Inc...

Organigram Announces Pricing of Overnight Marketed Public Offering

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today that, in connection with its previously...

Organigram Announces Launch of Overnight Marketed Public Offering

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units...

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment

North Carolina-based Open Book Extracts is a leading ingredient provider, product formulator and manufacturer...

Organigram Receives Health Canada’s Final Redetermination on Jolts

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced today that, despite strong evidence supporting its...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty

Revised Excise Framework Remains One of the Most Critical Reforms Required to Ensure the Long-Term Viability of the Cannabis Industry Organigram...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Organigram Reports First Quarter Fiscal 2024 Results

Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers...